SCHEMBL6268785

SCHEMBL6268785

CCOC(C)(Cn1cnc2c(=O)[nH]c(N)nc21)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 4/20 0.55
▸ BLM P54132 2/20 0.55
▸ USP2 O75604 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ EDNRA P25101 1/20 0.55
▸ HTR2A P28223 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ HBB P68871 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ TK1 P04183 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ VCP P55072 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ HPRT1 P00492 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16978925 0.84 PNP (0.60) PNPBLMUSP2TSHREDNRA
SCHEMBL24709497 0.83 PNP (0.59) PNPBLMUSP2TSHREDNRA
SCHEMBL874736 0.80 PNP (0.64) PNPBLMUSP2TSHREDNRA
SCHEMBL1767748 0.80 PNP (0.74) PNPBLMUSP2TSHREDNRA
SCHEMBL667796 0.78 TK1 (0.69) PNPBLMUSP2TSHREDNRA
SCHEMBL28591797 0.78 PNP (0.52) PNPBLMUSP2TSHREDNRA
SCHEMBL5181353 0.77 TK1 (0.65) PNPBLMUSP2TSHREDNRA
SCHEMBL9960816 0.77 PNP (0.68) PNPBLMUSP2TSHREDNRA
SCHEMBL29286376 0.77 TK1 (0.76) PNPBLMUSP2TSHREDNRA
SCHEMBL3855226 0.77 PNP (0.52) PNPBLMUSP2TSHREDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017394-B1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER REC TECH LTD (GB) 2005-12-07 — — EP disclosed
US-6303618-B1 ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2001-10-16 — — US disclosed
Send feedback